A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France - Institut Pasteur Access content directly
Preprints, Working Papers, ... Year : 2021

A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France

Abstract

The SARS-CoV-2 pandemic has entered an uncertain race between the emergence of variants that are more transmissible and vaccine roll-out. Here, we developed a mathematical model to evaluate how the interplay of variants, vaccines and non-pharmaceutical interventions might shape the pandemic dynamics, using the rise of the B.1.1.7 variant in metropolitan France as a case study. Our analysis highlights the challenges ahead for the management of the SARS-CoV-2 pandemic and shows how the quick roll-out of vaccines to at-risk individuals and non-pharmaceutical interventions are needed to mitigate the impact of the emerging variants.
Fichier principal
Vignette du fichier
Bosetti et al_Pasteur_variants and vaccination_2021.02.22.pdf (1.14 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

pasteur-03149525 , version 1 (23-02-2021)

Licence

Identifiers

  • HAL Id : pasteur-03149525 , version 1

Cite

Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Juliette Paireau, Daniel Levy Bruhl, et al.. A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France. 2021. ⟨pasteur-03149525⟩
5266 View
3113 Download

Share

Gmail Mastodon Facebook X LinkedIn More